EMS Facial Device vs Botox and Fillers, Can You Replace Injectables?
Medically reviewed by
4 independent reviewers
Andrew Conrad Barile, PT, DPT
Doctor of Physical Therapy (DPT) | Licensed Physical Therapist (PT) | CEO and Founder, Xtreem Pulse LLC
Read bio
Dr. Andrew Conrad Barile is a Doctor of Physical Therapy and the CEO and Founder of Xtreem Pulse LLC, the engineering company behind PureLift. He earned his Doctorate in Physical Therapy from Daemen College and is a licensed physical therapist.
He brings over two decades of clinical and entrepreneurial experience across physical therapy, craniosacral therapy and medical device innovation, built on a working knowledge of human anatomy and muscle physiology.
For PureLift LAB he reviews how current is delivered across all ten levels, from sub-sensory nanocurrent and skin-level microcurrent to motor-level EMS, and how the Infuse pass fits into the same ten-minute routine.
Bertica M. Rubio, M.D.
Board-Certified Physician, Dartmouth Medical School | Medical Director, Antiaging Regenerative Medicine Clinic
Read bio
Dr. Bertica M. Rubio is a board-certified physician and Medical Director of the Antiaging Regenerative Medicine Clinic in Redlands, California. She earned her Doctor of Medicine from Dartmouth Medical School and completed her pediatrics residency at UC Irvine Medical Center.
With decades of clinical experience, she specialises in age management medicine, regenerative medicine, wound healing and growth factor therapies, and her practice integrates evidence-based medical science with advanced aesthetic treatment.
For PureLift LAB she reviews articles for medical accuracy across the whole dial, from the gentle nanocurrent and microcurrent settings through to muscle-level EMS and the Infuse pass.
Daniel Grinberg, MD, FACS
Board-Certified Otolaryngologist | Head and Neck Surgeon | Fellow, American College of Surgeons | Mount Sinai
Read bio
Daniel Grinberg, MD, FACS is a board-certified otolaryngologist and head and neck surgeon at ENT and Allergy Associates in West Nyack, New York. He earned his medical degree from Columbia University College of Physicians and Surgeons.
He completed his otolaryngology residency at New York University Medical Center, serves as Assistant Clinical Professor at Mount Sinai School of Medicine, and is a Fellow of both the American College of Surgeons and the American Academy of Otolaryngology.
For PureLift LAB he brings a wider clinical lens, connecting at-home facial stimulation from microcurrent to EMS to the anatomy underneath, with the same rigour we apply to every device specification.
Prof. Dr. med. Ivo Buschmann
Chair of Angiology, Medizinische Hochschule Brandenburg | Clinic Director, University Clinic for Angiology
Read bio
Prof. Dr. med. Ivo Buschmann is Chair of Angiology at the Medizinische Hochschule Brandenburg Theodor Fontane and Clinic Director of the University Clinic for Angiology at the Brandenburg University Hospital.
He trained at the University of Hamburg, was a Max Planck Society Fellow at the Max Planck Institute for Heart and Lung Research, and held senior consultant posts at the Charite Universitatsmedizin Berlin before his appointment as Chair in 2016.
One of Europe's leading authorities on arteriogenesis, with over 150 peer-reviewed publications and US and EU patents, he reviews for PureLift LAB how the evidence on electrical stimulation is read and where its limits lie.
Share
No, a device does not replace injectables, and for one of the two it is aimed in the opposite direction entirely.
This article gives you the straight answer and the reasoning, such as:
- Why toxin and EMS point opposite ways
- Why muscle work cannot fill a crease
- The one job a device does that injectables do not
- How people combine all three sensibly
- What to ask before running a device over a treated area
and many more!
By the end you will know which of the three your own concern calls for.
Key Points:
Botulinum toxin reduces how strongly a muscle contracts and EMS produces contraction, so they are opposites rather than alternatives.
Filler replaces volume, and no amount of muscle work puts back fat that has gone.
What a device does that neither injectable does is build tone in the muscle layer, which is where a softening jawline lives.
None of the three is permanent, so the choice is which ongoing commitment suits you.
Ask the clinician who treated you when device use can resume, and follow their answer.
This question usually arrives from someone hoping the answer is yes, so here it is plainly: no, and not because a device is weak.
It is because the three approaches do three different jobs, and one of them is aimed in the opposite direction to the others.
Why toxin and EMS are opposites
Botulinum toxin works by reducing how strongly a specific muscle contracts, which softens the lines that muscle makes when it moves.
EMS works by making a muscle contract repeatedly, which builds tone in that muscle over weeks.
Read those two sentences together and the problem is obvious, since one reduces contraction and the other produces it.
So a device is not a gentler version of toxin, it is the reverse instruction, and using one to replace the other means asking for the opposite of what you wanted.
That is why the elevens between the brows, which come from muscles already working too hard, are the one facial concern where general toning logic runs backwards.
Why muscle work cannot replace filler
Filler occupies space, physically replacing volume where fat has thinned or a crease has formed.
Muscle sits underneath the skin, so training it improves the support beneath a crease without filling the crease itself.
A quick test: press gently beside a line, and if the crease flattens out, the shortfall is volume and filler is what addresses it.
We would rather tell you that than sell you twelve weeks of sessions for a problem they do not solve.
The job a device does that injectables do not
Around forty small muscles sit under the skin of your face, held inside a connected sheet called the SMAS, and engaging them repeatedly is how EMS supports a firmer, more defined look along the jaw, cheeks and neck with continued use.
In the largest facial trial of its kind, 108 women used daily muscle stimulation for twelve weeks and ultrasound measured an 18.6 percent increase in cheek-muscle thickness, with a clear difference from the untreated group at six weeks (Kavanagh 2012), and a double-blind sham-controlled trial in adults over 65 found muscle thickness and bite force increased after six weeks (Chang 2020).
Neither injectable builds muscle tone, so a softening jawline, a cheek losing its shape and a slackening neck are the territory where a device is the right tool rather than the cheap substitute.
Those are category studies run with their own devices, and no trial has compared a device against an injectable.
Matching the concern to the tool
Lines that appear when you move and vanish when your face is relaxed are toxin territory.
Hollowing, an emptied cheek, and creases that flatten when you press beside them are filler territory.
A blurring jaw, a slackening neck and a cheek losing definition are EMS territory.
Texture, dullness and fine lines are skincare territory, where sunscreen and a retinoid outperform everything else.
How people combine them
The common pattern is toxin for the elevens, filler for volume, and a device for tone through the jaw and neck, which is a division of labour rather than a competition.
None of the three is permanent, since toxin wears off, filler is absorbed, and muscle tone returns toward baseline if you stop training it.
So the real question is which ongoing commitment suits you, a booking every few months or ten minutes most evenings, and many people accept both.
Before running a device over a treated area
Ask the clinician who treated you when device use can resume, and follow their answer rather than a general rule from any article.
Do not run a device over an area treated recently without that guidance.
Injectables are medical procedures, and choosing a qualified practitioner matters more than choosing between these approaches.
The device routine, for comparison
All five PureLift models run nanocurrent at level 1, microcurrent at level 2, EMS from level 3 to 10, and Infuse as a second pass after the muscle work.
The session is three minutes on each side of the face at a level where you can see the muscle answer, followed by the Infuse pass, about ten minutes in total.
Face at $499 and Pro at $699 reach up to 7 milliamps, Pro Edition at $799 reaches up to 7.7, and Pro Plus + at $899 and GLOW at $999 reach up to 9, all measured at 500 ohms and always written as up to.
GLOW alone adds light, red at 634 nm cleared for the treatment of wrinkles, blue at 465 nm cleared for mild-to-moderate inflammatory acne, and purple, which is red and blue running together.
Every model is cleared through the FDA 510(k) pathway, under records K190269 for Face, K230506 for Pro and Pro Edition, K221443 for Pro Plus + and K243587 for GLOW, and clearance is a safety review rather than a promise about results.
All five are made in Japan in an ISO 13485 facility.
Anyone with a pacemaker or another implanted electronic device, anyone pregnant, and anyone with epilepsy or a seizure disorder should not use the device at all.
For the cost side, read what can be compared, and for the layers, read facial muscle anatomy.
Model figures verified on 9 September 2026 against the PureLift LAB store and FDA records K190269, K230506, K221443 and K243587. Every model runs nanocurrent, microcurrent, EMS and Infuse; consumer copy always says up to. This article is general cosmetic information and is not medical advice.
This comparison sits inside our full map of the category, where we set out all 33 devices we track, what each one carries and what each brand publishes: Nine Technologies on One Dial, What the Rest of the Market Actually Carries.
Two related questions come up often alongside this one, and we have answered both in full: the full safety picture, including who should not use one, and the timing around botox and fillers.